vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and GRAHAM CORP (GHM). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $56.7M, roughly 1.5× GRAHAM CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 5.0%, a 17.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 20.5%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $2.4M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 7.5%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
FDMT vs GHM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $56.7M |
| Net Profit | $19.4M | $2.8M |
| Gross Margin | — | 23.8% |
| Operating Margin | 17.3% | 5.5% |
| Net Margin | 22.8% | 5.0% |
| Revenue YoY | 8508900.0% | 20.5% |
| Net Profit YoY | 139.1% | 79.2% |
| EPS (diluted) | $0.43 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $56.7M | ||
| Q3 25 | $90.0K | $66.0M | ||
| Q2 25 | $15.0K | $55.5M | ||
| Q1 25 | $14.0K | $59.3M | ||
| Q4 24 | $1.0K | $47.0M | ||
| Q3 24 | $3.0K | $53.6M | ||
| Q2 24 | $5.0K | $50.0M | ||
| Q1 24 | $28.0K | $49.1M |
| Q4 25 | $19.4M | $2.8M | ||
| Q3 25 | $-56.9M | $3.1M | ||
| Q2 25 | $-54.7M | $4.6M | ||
| Q1 25 | $-48.0M | $4.4M | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | $-43.8M | $3.3M | ||
| Q2 24 | $-35.0M | $3.0M | ||
| Q1 24 | $-32.4M | $1.3M |
| Q4 25 | — | 23.8% | ||
| Q3 25 | — | 21.7% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 24.8% | ||
| Q3 24 | — | 23.9% | ||
| Q2 24 | — | 24.8% | ||
| Q1 24 | — | 25.9% |
| Q4 25 | 17.3% | 5.5% | ||
| Q3 25 | -67983.3% | 6.5% | ||
| Q2 25 | -396373.3% | 8.9% | ||
| Q1 25 | -383007.1% | 9.3% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | -1704400.0% | 7.9% | ||
| Q2 24 | -849120.0% | 6.5% | ||
| Q1 24 | -136200.0% | 3.1% |
| Q4 25 | 22.8% | 5.0% | ||
| Q3 25 | -63195.6% | 4.7% | ||
| Q2 25 | -364386.7% | 8.3% | ||
| Q1 25 | -342657.1% | 7.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | -1461433.3% | 6.1% | ||
| Q2 24 | -699060.0% | 5.9% | ||
| Q1 24 | -115717.9% | 2.7% |
| Q4 25 | $0.43 | $0.25 | ||
| Q3 25 | $-1.01 | $0.28 | ||
| Q2 25 | $-0.98 | $0.42 | ||
| Q1 25 | $-0.86 | $0.40 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.79 | $0.30 | ||
| Q2 24 | $-0.63 | $0.27 | ||
| Q1 24 | $-0.66 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $22.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $131.3M |
| Total Assets | $566.7M | $292.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $22.3M | ||
| Q3 25 | $305.1M | $20.6M | ||
| Q2 25 | $293.2M | $10.8M | ||
| Q1 25 | $321.4M | $21.6M | ||
| Q4 24 | $424.9M | $30.0M | ||
| Q3 24 | $501.9M | $32.3M | ||
| Q2 24 | $541.9M | $21.6M | ||
| Q1 24 | $525.9M | $16.9M |
| Q4 25 | $505.7M | $131.3M | ||
| Q3 25 | $369.0M | $127.6M | ||
| Q2 25 | $420.9M | $123.4M | ||
| Q1 25 | $469.7M | $119.6M | ||
| Q4 24 | $510.6M | $114.4M | ||
| Q3 24 | $552.9M | $112.5M | ||
| Q2 24 | $588.3M | $108.2M | ||
| Q1 24 | $600.6M | $105.6M |
| Q4 25 | $566.7M | $292.9M | ||
| Q3 25 | $424.0M | $287.0M | ||
| Q2 25 | $473.6M | $252.3M | ||
| Q1 25 | $515.7M | $264.1M | ||
| Q4 24 | $560.4M | $264.3M | ||
| Q3 24 | $604.0M | $249.5M | ||
| Q2 24 | $620.1M | $244.2M | ||
| Q1 24 | $629.9M | $233.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $4.8M |
| Free Cash FlowOCF − Capex | $28.5M | $2.4M |
| FCF MarginFCF / Revenue | 33.5% | 4.3% |
| Capex IntensityCapex / Revenue | 0.1% | 4.1% |
| Cash ConversionOCF / Net Profit | 1.47× | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $-6.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $4.8M | ||
| Q3 25 | $-46.5M | $13.6M | ||
| Q2 25 | $-43.4M | $-2.3M | ||
| Q1 25 | $-47.8M | $-3.6M | ||
| Q4 24 | $-134.6M | $5.2M | ||
| Q3 24 | $-29.4M | $13.9M | ||
| Q2 24 | $-30.2M | $8.7M | ||
| Q1 24 | $-29.1M | $8.6M |
| Q4 25 | $28.5M | $2.4M | ||
| Q3 25 | $-46.6M | $9.4M | ||
| Q2 25 | $-43.4M | $-9.3M | ||
| Q1 25 | $-48.4M | $-8.7M | ||
| Q4 24 | $-138.4M | $-2.1M | ||
| Q3 24 | $-31.2M | $10.4M | ||
| Q2 24 | $-30.6M | $5.7M | ||
| Q1 24 | $-29.8M | $4.6M |
| Q4 25 | 33.5% | 4.3% | ||
| Q3 25 | -51765.6% | 14.3% | ||
| Q2 25 | -289620.0% | -16.7% | ||
| Q1 25 | -345635.7% | -14.7% | ||
| Q4 24 | -13837100.0% | -4.5% | ||
| Q3 24 | -1038966.7% | 19.5% | ||
| Q2 24 | -611840.0% | 11.5% | ||
| Q1 24 | -106421.4% | 9.4% |
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | 101.1% | 6.3% | ||
| Q2 25 | 440.0% | 12.6% | ||
| Q1 25 | 4507.1% | 8.7% | ||
| Q4 24 | 378600.0% | 15.6% | ||
| Q3 24 | 59266.7% | 6.5% | ||
| Q2 24 | 6980.0% | 6.0% | ||
| Q1 24 | 2535.7% | 8.2% |
| Q4 25 | 1.47× | 1.67× | ||
| Q3 25 | — | 4.40× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | — | -0.81× | ||
| Q4 24 | — | 3.29× | ||
| Q3 24 | — | 4.25× | ||
| Q2 24 | — | 2.94× | ||
| Q1 24 | — | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
